XCounter AB
http://www.xcounter.se
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From XCounter AB
Breast Cancer: Improving the Odds
Breast cancer is the most common type of female cancer and the number two cancer killer in US women. Treatment options continue to expand and researchers are making steady advancements in cancer detection that they hope will one day enable most breast cancer cases to be diagnosed an an early, very curable stage.
Is London's AIM the New Nasdaq? Not Yet.
Some observers see London's ten-year old junior market for high-growth, small-to-mid-cap companies as, if not a Nasdaq-in-waiting, then certainly the most likely exchange to rival it. But although AIM is attracting growing numbers of overseas companies, some sheltering from Sarbanes-Oxley, liquidity and follow-on financing issues remain. AIM isn't Europe's Nasdaq, not yet.
Company Information
- Industry
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- X-ray
-
Diagnostic Imaging Equipment & Supplies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice